Caplight Directory>Companies>KeViRx, Inc.-preview>Kevirx


KeViRx, Inc.

KeViRx, Inc.

Private
Charlottesville, VirginiaHealthcare & Life Scienceshttps://kevirx.com

Last Round

Accelerator

Aug 28, 2024

Total Funding Raised

$2.45M

Company Overview

KeViRx, Inc. is a preclinical stage biotechnology company that develops small molecule drugs to treat microvascular leakage and inflammation for diseases such as acute lung injury.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

small molecule drugPTP4A3 phosphatase inhibitoracute lung injuryALIcancer therapeuticsfirst-in-class therapeuticallosteric inhibitoracute respiratory distress syndromeARDShost-directed therapyendothelial barrier repairmicrovascular leakageinsult-agnostic therapypharma licensingpre-clinical biotechearly-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KeViRx, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KeViRx, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorAug 28, 2024
GrantJun 11, 2024
GrantAug 29, 2022
GrantSep 20, 2021
GrantJun 18, 2020
View all Funding Rounds

KeViRx, Inc. Investors

Notable investors and investment history

InvestorRounds
U.S. Department of DefenseGrant
Virginia Innovation Partnership CorporationGrant
National Heart, Lung, and Blood InstituteGrant
View all Investors

KeViRx, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KeViRx, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KeViRx, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlottesville, Virginia
Employee Range5
Year Founded2016
Last FundingAug 28, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.